Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Colonic Neoplasms 50Rectal Neoplasms 49Colorectal Neoplasms 36Pancreatic Neoplasms 10Unspecified Adult Solid Tumor, Protocol Specific 9Neoplasm Metastasis 8Stomach Neoplasms 7Ovarian Neoplasms 6Carcinoma, Hepatocellular 6Lymphoma, Large B-Cell, Diffuse 5Gallbladder Neoplasms 5Carcinoma, Ovarian Epithelial 5Bile Duct Neoplasms 5Burkitt Lymphoma 4Appendiceal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Neoplasms 3Fallopian Tube Neoplasms 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Osteosarcoma 2Optic Nerve Glioma 2Neurotoxicity Syndromes 2Neuroectodermal Tumors, Primitive, Peripheral 2Nasopharyngeal Neoplasms 2Melanoma 2Lymphoma, T-Cell, Peripheral 2

Interventions

Carboplatin 3Temozolomide 2Etoposide 2Bleomycin 2ixabepilone 1Vinblastine 1PT-100 dipeptide 1Oxaliplatin 1O(6)-benzylguanine 1Ifosfamide 1Cisplatin 1Chemotherapy, Adjuvant 1Analgesia 1ABT751 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Ovarian Germ Cell Cancer × Oxaliplatin × Clear all
NCT00091182 2013-06-05

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

National Cancer Institute (NCI)

Phase 2 Completed
180 enrolled
CNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

Familial ependymoma, Ovarian Germ Cell Cancer, Astrocytoma, Carcinoma, Renal Cell, Colonic Neoplasms, Nasopharyngeal Neoplasms, Neuroblastoma, Rectal Neoplasms, Osteosarcoma, Teratoma, Testicular Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Adrenocortical Carcinoma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡